Across TCGA pan-cancer cohorts, OR4K12P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated OR4K12P data layer.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher OR4K12P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR4K12P expression acts as an unfavorable survival marker, although some lineages such as ESCA and BRCA show a favorable association.
KIRP, KICH, and UCEC are the cancer types where OR4K12P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.